Information for Prescribers
State-specific disclosure information for licensed healthcare practitioners
Information for Colorado Prescribers of Prescription Drugs Provided Pursuant to Colorado Rev. Stat. § 12-280-308
Information for Connecticut Prescribers of Prescription Drugs Provided Pursuant to Connecticut HB 6669
Marketed Prescription Drug
Danyelza (naxitamab-gqgk) 40mg/10mL Injection
Current WAC
$26,065.90 per vial
Generic Alternatives (if applicable)
At this time there are no generic therapeutic alternatives to Danyelza
Information on the variation efficacy of the legend (prescribed) drug noted above, in different racial and ethnic groups, if such information is available, can be found in the drug’s FDA approved Prescribing Information document, which can be accessed at https://labeling.ymabs.com/danyelza.